[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-FULC":3,"homepage-market-summary":31,"stock-news-FULC":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"FULC","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Fulcrum Therapeutics, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.","55","Cambridge, MA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},3.69,3.72,3.76,3.65,3.68,0.01,0.27,1539908.061503,8586,3.6824,15.74,2.83,1553486.559511744,6.7,1814,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":155},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":40,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.13,110.04,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.25,80.53,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.4,62.95,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.78,169.95,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.66,48.86,{"name":141,"etf":142,"change":143,"price":144,"is_up":40},"Real Estate","XLRE",0.32,40.81,{"name":146,"etf":147,"change":148,"price":149,"is_up":40},"Utilities","XLU",0.38,39.83,{"name":151,"etf":152,"change":153,"price":154,"is_up":40},"Comm Services","XLC",0.35,110.32,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":40},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":162,"name":163,"price":164,"change":90,"is_up":40},"QQQ","Invesco QQQ Trust",749.58,{"ticker":166,"name":167,"price":168,"change":54,"is_up":40},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":170,"name":171,"price":172,"change":68,"is_up":40},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":174,"articles":175},5,[176,182,188,194,200],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (NA - The National Law Review","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxORVZVS2Viam1iQjk3aTF0MGRHNmg1SzhvRWFwRlZ0S19TWmFMeS1aMmV0SXpmYzdGTTM2Wi1QMlR0eVJ2SUQyRHc5RmdjUFFQcTZRVG5TS1ZPRk1id0JGdlNyVlZuUUY1VWZTLXlWajJwMmw1a25ZQXppWTVLZTNMTXhMcXM5RUU2M1otc1RtUlc0OTlGUHd3TVpUY1NfZGNGeWo0M1QyeVNOWjJqemkwV01R?oc=5","Wed, 30 Sep 2026 03:54:25 GMT","Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (NA The National Law Review","The National Law Review",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"Are FULC, TCBK, LXP Obtaining Fair Deals for their Shareholders? - PR Newswire","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxPRlY2N2N0ZTcwdUxiMnk5VG90LXNJSmd0eWFDWW9ZTUkzQlg3ZjdfSEJFMWhwc0dBNGxpM3lmZFBKQ2VVYnNPLUdQSnh0R2xlMnJMbFNnRGVNZFdYaWhiZ0U3N0J0Z2RjVmdIY2tua3hZOExEVFpDaU5RMjNZcTIzUkZRcTRXR0pMNlpoaGRFaS02VmtDTV9STVdhUnFFUkFoUUdRRnpKNV9GTGRyUUliZUFITlZmNWk0?oc=5","Fri, 25 Sep 2026 11:39:00 GMT","Are FULC, TCBK, LXP Obtaining Fair Deals for their Shareholders? PR Newswire","PR Newswire",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"Fulcrum Therapeutics (FULC) Holds Steady at $3.77 as Traders Eye Range Boundaries - Bullish Pattern Stocks - siam.in","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxPeGRqV1k0YUdldTNQell2S2FZQ2xwN0FkZFF2b1pHUHdvdjhoMzU1aThWLUQ1bGtkdUpDN2JOc1hTNDR4UU8taU9sVlc3WjFmQlI1cGNYa01jOHRnS1cyS1JnV21MSFZtaTlRM2gxdHFmWUFQUTNuYlZrR3htSGNab0M4aGRtSXdlMVFyTU9ITThmcXdvakRNV1dEUl80SEVxdFUtTDNZcnpBdU5PNHM4ZVVocUdQNUUya09PVA?oc=5","Mon, 21 Sep 2026 15:40:22 GMT","Fulcrum Therapeutics (FULC) Holds Steady at $3.77 as Traders Eye Range Boundaries - Bullish Pattern Stocks siam.in","siam.in",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"Fulcrum Therapeutics (FULC) Holds Steady at $3.77 as Traders Eye Range Boundaries - Investment Factor - dars.gov.et","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi-gFBVV95cUxQazVwaHR6UFRpRGlpUV9mRWt0emY4SWtUWF81eThTMHdFTGZDekY5RUs4UWVOV3pZWFdSN18xcEVfQ3dEeE5RbURXZmlSNFBnbnBmNklnZWdBaHRRYlgzU1ZXRF9BRnJzS3JTVC1MTTVYb29DTGRyLWx2YWNsanBBc1BWMTY0RjZYblliakx0RG1sYWZZWm03RWROV1ZjM0xQSTFCelFnRDVKYWxNNHllOFVNZWpEamxVMnhTNnIzbmlBVldwMEdORWJUVG91SXJseTlnUVF0cE5TTDU5VjYtRmxwUXBJUGh6SlJydGhldlA4TXRyOW9kZDZB?oc=5","Mon, 21 Sep 2026 15:31:07 GMT","Fulcrum Therapeutics (FULC) Holds Steady at $3.77 as Traders Eye Range Boundaries - Investment Factor dars.gov.et","dars.gov.et",{"title":201,"link":202,"pubDate":203,"description":204,"source":205},"TPG Mortgage IT Q2FY26 Results: EAD covers dividend, acquires Cherry Hill - scanx.trade","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxPblhKclFGdEdtN3JlRms1UnpBOVhHWXhsYWNuMVpSSTd0NFl0RnVKc2NBYmlHajA2aHlMNTFKaC1PdHkzWGxJaGI3aUF3akVSSkNHNzZJT0lYOXNPR3VrSlJSaTZTdS1rd2VJSG93a3JoVG9vTkhqaDZ1ZTRnQm1KZVpDLUFkTktJaXd2X3ZWWWd1NDltOUFMTXFZNlpvTFhCbmYxTkhCNU50ZDYyVGNGWG5XX29YeW5JanRocV9Yd2w?oc=5","Mon, 21 Sep 2026 07:00:00 GMT","TPG Mortgage IT Q2FY26 Results: EAD covers dividend, acquires Cherry Hill scanx.trade","scanx.trade"]